agilon health inc. Financial Ratios
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
82.39-2.33 (-2.75%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
agilon health inc. ratio analysis
agilon health inc. earned a net margin of -6.6% in FY 2025, down from -4.3% a year earlier. Return on equity reached -308.8%, meaning agilon health inc. generated -3.09 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.28 versus 0.07 the year before, and the current ratio was 1.02.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
agilon health inc. financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Price / sales | 1.18 | 3.54 | 29.72 | 68.96 | 165.45 | — | — |
| Price / book | 55.04 | 45.59 | 193.85 | 158.17 | 230.54 | — | — |
| Operating margin | -7.8% | -4.8% | -5.4% | -4.4% | -24.5% | -4.7% | -13.4% |
| Net margin | -6.6% | -4.3% | -6.1% | -4.5% | -26.7% | -4.9% | -35.6% |
| Free cash flow margin | -2.0% | -1.2% | -4.0% | -6.1% | -10.2% | -4.5% | -13.4% |
| Return on equity (ROE) | -308.8% | -55.2% | -39.7% | -10.2% | -37.2% | — | — |
| Return on assets (ROA) | -30.8% | -15.0% | -15.1% | -6.3% | -25.6% | -13.5% | — |
| Debt / equity | 0.28 | 0.07 | 0.06 | 0.04 | 0.04 | — | — |
| Current ratio | 1.02 | 1.27 | 1.51 | 2.71 | 3.83 | 1.10 | — |
| Revenue growth | -2.1% | 40.4% | 80.7% | 57.0% | 24.9% | 53.4% | — |